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Abstract 
The prevalence of nonalcoholic fatty liver disease (NAFLD) as a metabolic disorder affecting the 
liver function is rapidly increasing and there is a need to develop new and more efficient treat-
ment. This study was designed to evaluate the protective effect of  Cichorium intybus L. and Cinna-
mon mixture infusion (2.5 and 0.5 g/100mL and twice/day) on patients with NAFLD. This be-
fore-after clinical trial study was performed on 25 patients with NAFLD. They were administered 
the mixture of extract prepared in special bags twice a day for 30 days. Hepatic and metabolic 
markers of NAFLD like alanine aminotransferase (ALT), aspartate aminotransferase (AST), alka-
line phosphates (ALP), fasting blood sugar (FBS), cholesterol (chol), triglycerides (TG), high-den- 
sity lipoprotein (HDL) and low-density lipoprotein (LDL) in plasma and also, fatty liver ultrasono-
graphic grading were determined before and after using the extracts. 30-day treatment with ex-
tracts in NAFLD patients resulted in a significant decrease in ALT and AST. FBS, TG and ALP were 
also decreased after administration of the extracts but not significantly. A significant linear corre-
lation was found between age and ALP, and between gender and liver enzymes. It is concluded that 
the mixture of Cichorium intybus L. and Cinnamon extracts has some benefits in NAFLD patients 
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making them valuable for future investigations. 
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1. Background 
As a result of obesity epidemic, non-alcoholic fatty liver disease (NAFLD) is going to be the most important 
liver disease in the near future. The clinical significance of NAFLD is derived mostly from its manifestation in 
metabolic disruption and in its possible progression to end-stage liver failure. Many pathological conditions 
have been associated with NAFLD, such as diabetes mellitus, hyperlipidemia, obesity, metabolic syndrome and 
cardiovascular diseases. Historically, the first therapeutic line of NAFLD was non-pharmacologic measures 
consisted of diet and lifestyle modification in order to weight loss and control of associated metabolic disorders. 
However, the issue was always enough important and concerning for medical scientist to find pharmacologic 
approach, and efficacy of many drugs such as metformin, thiazolidinediones, vitamin E, betaine, N-acetyl- 
cysteine, ursodeoxycolic acid (UDCA), and probucol has been investigated for treating NAFLD afflicting pa-
tients. Nevertheless, none had a demonstrating effective resolution of NAFLD, and finding a proper and effec-
tive therapy is under different trials [1]-[3]. 
On the other hand, there has always been a tendency among medical researchers to seek remedial agents 
among traditional sources. In this respect, lots of plant extracts have been evaluated for their effectiveness in 
metabolic disorders. Cinnamomum zeylanicum and Cichorium intybus L. (Chicory or Kasni) have a long history 
of therapeutic use in traditional medicine for various diseases particularly diabetes and hepatic problems. Cin-
namomum zeylanicum has been repeatedly investigated for its promising role in alleviation of diabetes and me-
tabolic syndrome through increasing insulin sensitivity [4]-[8]. Chicory seed extract has also been tested and 
shown to have improving effects on pancreatitis, diabetes presentations, insulin signaling, and NAFLD in expe-
rimental set-ups [9]-[13]. 
The aim of this study was to determine the capability of  Cichorium intybus L. and Cinnamon mixture infusion 
(2.5 and 0.5 g/100mL and twice/day) on patients with NAFLD.  
2. Material and Method 
To meet the aim of this study, 25 patients with NAFLD diagnosis who referred to the tertiary centre GI Clinic of 
Zahedan University of Medical Sciences were studied in 2012. The study protocol was approved by Tehran 
University of Medical Sciences Ethics Committee. All included patients had no history of coronary artery dis-
ease, alcohol or alcoholic beverages consumption, insulin-dependent diabetes, bleeding diathesis, severe anemia, 
and cancer within the past 5 years. There were no use of anti-coagulants and cyclosporine and conditions likely 
to lead to death within 5 years. Any conditions of chronic liver disease such as viral, metabolic, hereditary and 
autoimmune were excluded by detailed history and appropriate tests. Trans-abdominal ultrasonography and ul-
trasonography fatty liver grading were used for diagnosis by an experienced sinologist in all subjects before and 
after trial. According to the Declaration of Helsinki, all participants were provided with specific written infor-
mation about the aims of the study before consents were obtained. Prior to blood collection, each individual was 
extensively interviewed by a specialized physician who filled in a structured questionnaire about disease and 
habit diet. The included subjects were administered  Cichorium intybus L. and Cinnamon mixture infusion (2.5 
and 0.5 g/100mL, twice/day) for 30 days at 7.5 am and 2 pm every day. A supervisor carefully checked to make 
sure that the volunteers were taking infusion properly. Blood samples were collected from all subjects before 
using Cichorium intybus L. and Cinnamon infusion and 12 hours after the last dose of 30-day treatment with in-
fusion. 
2.1. Plant Material 
Cinnamomum and Cichorium intybus L. were supplied by Arak Medicinal Plants Company and identified as 
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Cinnamon zeylanicum and Cichorium intybus L.  
2.2. Infusion Preparation and Protocol 
The subjects were instructed how to prepare the infusion by mixing a total of (2.5 and 0.5 g/100mL) Cinnamon 
and Cichorium intybus L. infusion in 100 mL 98˚C water for 30 minutes (Katalinic et al., 2006). A qualified 
expert supervised the whole procedure. 
2.3. Biochemical Analysis of Serum Parameters 
All biochemical serum analysis including alanine aminotransferase (ALT), aspartateamino transferase (AST), 
alkaline phosphates (ALP), fasting blood glucose (FBS), cholesterol (CL), triglycerides (TG), high-density lipo-
protein (HDL) and low-density lipoprotein (LDL) were performed with Pars test kits in the same laboratory. 
2.4. Statistical Analysis 
Results are presented as mean ± SD. Statistical analyses were conducted using SPSS software (version 18). The 
paired t-test and Wilcoxon Matched-Pairs Signed-Ranks Test analysis were applied to this study and associa-
tions between parameters were determined through Pearson correlation analysis. Value of p < 0.05 was consi-
dered statistically significant. 
3. Results 
The mean ± SD values for age and BMI and sex percentage of subjects have been showed in Table 1. After us-
ing Cinnamon and Cichorium intybus L. infusion, ALT activity decreased significantly (p = 0.003). The before 
and after mean ± SD were 51.20 ± 37.16 and 36 ± 21.43, respectively. A decrease in AST activity was also ob-
served after administration of the infusion (41.20 ± 23.87 before versus 29 ± 17.73 after, p = 0.000). A decrease 
(p = 0.419) in ALP activity was observed by using the infusion. The mean ± SD before and after using were 
201.40 ± 57.92 and 191.95 ± 80.11. Moreover a decrease (p = 0.065) in FBS was observed by using the infusion. 
The mean ± SD before and after using were 99.30 ± 12.90 and 96.80 ± 10.83. Also a decrease in TG was ob-
served after administration of the infusion (150.70 ± 82.60 before versus 138.80 ± 53.82 after, p = 0.394). On 
the other hand, a decrease (p = 0.402) in HDL was observed by using the infusion. The mean ± SD before and 
after using infusion were 78.15 ± 129.49 and 53.55 ± 27.26. However an increase in cholesterol was observed 
after administration of the infusion (173.72 ± 66.96 before versus 187.39 ± 37.90 after, p = 0.346) (Table 2). 
Analysis by Wilcoxon Matched-Pairs Signed-Ranks Test showed a significant decrease in grade of sono-
graphic examination (p = 0.020). 
A significant linear correlation was found between age and ALP (df = 1.24, F = 5.753 and p = 0.028). How-
ever, linear correlation was found between gender and ALT (df = 1.24, F = 6.380 and p = 0.021) and gender and 
AST (df = 1.24, F = 6.832 and p = 0.018). 
 
Table 1. Demographic data of study subjects.                                                                  
Subjects Age Sex BMI 
Patients (n = 25) 43.55 ± 17.28 Male (45%), Female (55%) 27.59 ± 2.81 
 
Table 2. The effect of aqueous extract of Cinnamon and Cichorium intybus L. on liver biochemical enzymes parameters.       
Biochemical tests Before After p value 
FBS 99.30 ± 12.90 96.80 ± 10.83 0.065 
TG 150.70 ± 82.60 138.80 ± 53.82 0.394 
Chol 173.72 ± 66.96 187.39 ± 37.90 0.346 
HDL 78.15 ± 129.49 53.55 ± 27.26 0.402 
AST 41.20 ± 23.87 29.00 ± 17.73 0.000 
ALT 51.20 ± 37.16 36.00 ± 21.43 0.003 
ALP 201.40 ± 57.92 191.95 ± 80.11 0.419 
Z. S. Asl et al. 
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4. Discussion 
The present study evaluated the effect of extract of Cinnamon and Cichorium intybus L. on determinant para-
meters of hepatic function in NAFLD patients. Except HDL and cholesterol, the other factors including FBS, 
TG, AST, ALT, and ALP have been partially improved by infusion of the extracts, and interestingly the de-
crease in AST and ALT was significant. 
As a complex metabolic disorder manifested in the liver, NAFLD not only can lead to fibrosis, cirrhosis, and 
liver-related death, but also is considered a serious risk factor for cardiovascular diseases and metabolic syn-
drome. NAFLD is etiologically accompanied with insulin resistance which makes disruption of the main para-
meters of glucose and lipid metabolism expectable. So, monitoring these parameters is logical and useful for 
evaluating progression and clinical symptoms of the disease. 
By using Cinnamon and Cichorium intybus L. extracts in this study, no remarkable change was observed in 
FBS, TG, cholesterol, and HDL level of NAFLD patients. This can be explained as theses parameters were in 
the normal range before starting the treatment and there was no expectation to have significant change. 
The AST/ALT ratio was in the normal range (less than 1) giving no probability of liver damage due to cirrho-
sis, alcoholic hepatitis, and hepatocellular carcinoma. Furthermore, ALP was decreased after treatment with ex-
tracts but the change was not significant indicating that the extract had no or partial effect on bile duct obstruc-
tion if existed. Significant decrease in the level of serum transaminases ALT and AST, and grade of sonographic 
examination was the good point of this study, though effectiveness of Cinnamon and Cichorium intybus L. ex-
tracts in NAFLD patients should be more confirmed. 
There are several in vitro, animals, and/or human studies implicating on protective effects of cinnamon extract 
on insulin resistance, type 2 diabetes and metabolic syndrome [6] [14]. Cichorium intybus L. has also been 
shown to ameliorate experimental diabetes and NAFLD in rats via modulating the expression of peroxisome 
proliferator-activated receptors (PPARs) and sterol regulatory element-binding protein-1 (SREBP-1) genes in 
hepatocytes. PPARs are nuclear fattyacid receptors with known role in lipid and carbohydrate homeostasis via 
activating fatty acid catabolism and are molecular target of related pharmacologic agents including lipid lower-
ing fibrates and insulin sensitizing thiazolidinediones. SREBPs also include a family of membrane-bound tran-
scription factors regulating cellular pathways involved in insulin response and lipid metabolism. In this respect, 
PPARs ligands and modulators of SREBPs show promising strategies for treatment of NAFLD [13]. Cichorium 
intybus L. has also been shown to enhance glucose uptake and improve insulin sensitivity through inhibiting 
protein tyrosine phosphatase 1B (PTP1B) in adipogenic insulin signaling cascade both in vitro and in vivo [9]. 
5. Conclusion 
It would be concluded that the therapeutic potential of cinnamon that is the possible mechanism of this activity 
may be free radical-scavenging polyphenol compounds [15] [16] and Cichorium intybus L. due to hepatoprotec-
tive effect on esculetin and a phenolic compound. Cichotyboside, a guaianolide sesquiterpene glycoside [17] [18] 
resulted in improving NAFLD, however the extracts has worth to be more evaluated for treating NAFLD and 
related complications. The limitations of the study were the lack of evaluating liver tissue and also the lack of 
controlling diet and activity.  
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Abbreviation 
Nonalcoholic fatty liver disease (NAFLD) 
Alanin aminotransferase (ALT) 
Aspartate aminotransferase (AST) 
Alkaline phosphates (ALP) 
Fasting blood sugar (FBS) 
Cholesterol (chol) 
Triglycerides (TG) 
High-density lipoprotein (HDL) 
Low-density lipoprotein (LDL) 
Ursodeoxycolic acid (UDCA) 
Peroxisome proliferator-activated receptors (PPARs) 
Sterol regulatory element-binding protein-1 (SREBP-1) 
Protein tyrosine phosphatase 1B (PTP1B) 
